Feed IIPR-PA
II

Innovative Industrial Properties, Inc. 9.00% Series A Cumulative Redeemable Preferred Stock IIPR-PA · NYSE

$23.93 -0.42% (-$0.10)

Summary

72 / 100 · Bulios Score

What speaks for it

  • Out of every 100 USD of revenue, 52 USD is left as net profit.
  • The share price is below the Bulios Fair Price.
  • It bought back its own shares for $20.1M in the last fiscal year, 42% of its market value.

What to watch

  • Earnings per share fell by 11% a year over the last 3 years.
  • It missed profit estimates 4 times in the last 8 quarters.
  • Analysts expect revenue to fall by 4.9% this fiscal year.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $23.93
P/E today 0.3
REIT - Industrial industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 0.3 USD for 1 USD of yearly profit.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 18% a year over 5 years. Over the last 3 years it fell by 1.3% a year. For the next fiscal year analysts expect revenue to fall by 4.9%. Earnings per share fell by 11% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 USD of revenue goes

Net profit, industry median (REIT - Industrial) 42 USD

Out of every 100 USD of revenue, 52 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Mostly

Repaying all its debt would take 3.1 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, stretched
Yield
9.36%
Paid out of profit
3.2%

You receive $2.25 per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

Neutral

No analyst has published a price target.

29% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy